Genotech Corporation provides products and services for gene synthesis, genome analysis, and biopharmaceuticals in South Korea and internationally. The company offers standard, modified, dual labeled, and synthesis oligonucleotides; and gene synthesis services. It also provides sanger DNA sequencing services, which includes standard DNA, 16S/ITS, and insert clone sequencing, as well as primer walking; next generation sequencing; bioinformatics services; genomic services, such as SNP discovery/analysis and sequence finishing; and molecular diagnostic kits. In addition, the company provides active pharmaceutical ingredients, such as vancomycin HCI, teicoplanin, and tacrolimus. Further, its bio-pharma research activities include development of incrementally modified drug and identification of new molecular entities through its functional genomics and metabolic reconstruction technologies. Genotech Corporation was founded in 1997 and is headquartered in Daejeon, South Korea.